Core Insights - The article emphasizes the importance of self-acknowledgment and personal growth, particularly in the context of the booming health industry driven by the "Healthy China" strategy, with the market expected to exceed 10 trillion yuan by 2025 [1] - The company, Taikang Insurance Group, is launching a recruitment plan for its "Health Business Partners" in 2026, marking its 30th anniversary and aiming to capitalize on the "longevity era" [1] Group 1: Business Model Innovation - Taikang proposes an innovative "payment + service + investment" model for the new life insurance era, integrating virtual insurance with physical healthcare services to create three major closed loops: longevity, health, and wealth [2] - The new model focuses on a holistic approach to client service, expanding beyond traditional insurance sales to include health management, retirement planning, wealth management, investment portfolios, legal and tax advice, and family inheritance [2][3] Group 2: Marketing and Support Strategies - The company employs a unique "super body marketing" system that transforms insurance from a "cold product" into a "warm service," enhancing the relationship between agents and clients through immersive experiences [4] - Taikang provides a comprehensive training system and clear promotion pathways, enabling agents to grow from novices to experts, supported by the strength of a Fortune 500 company [5] Group 3: Future Vision and Opportunities - Taikang's 30-year journey is characterized by innovation and commitment, and the company seeks partners who are willing to grow alongside it in a career that offers both social value and personal achievement [6] - The "Health Business Partner" program invites individuals to join Taikang in defining their future in the health wealth management sector, emphasizing the potential for personal value maximization in a limitless environment [6]

Group 1 - Wanhua Chemical's Yantai Industrial Park's ethylene unit has completed a technical upgrade and resumed production, achieving flexible feedstock switching between ethane and propane, enhancing competitiveness in the petrochemical industry [1] - United Water has won a long-term operation contract for municipal wastewater treatment in Saudi Arabia, with an estimated total investment of approximately 378 million RMB over a 15-year cooperation period [2] - Minsheng Health plans to invest 98 million RMB to establish a fund focused on the health industry, contributing 49% of the total fund size of 200 million RMB [3] Group 2 - Jialitu's shareholder, Anle Group, plans to reduce its stake by up to 3% of the company's total shares [4] - Laiyifen's controlling shareholder intends to reduce its stake by no more than 3% of the total shares [5] - Taifu Pump's actual controller's concerted action party plans to reduce its stake by up to 0.535% [7] Group 3 - Vanke A's executive vice president, Yu Liang, has resigned due to retirement [8] - Tian Sheng New Materials has suspended trading due to a potential change in control involving its largest shareholder [10] - Taisun Wind Power is in the early stages of business layout in the commercial aerospace sector [11] Group 4 - Lushin Investment holds only 0.89% equity in Blue Arrow Aerospace, indicating minimal impact on its financial status [12] - Huibo Pu's controlling shareholder is planning a change in control, leading to stock suspension [13] - Tubaobao's subsidiary is selling a stake in Daziran Home and acquiring specific equity for 4 billion RMB [14] Group 5 - Xingchen Technology plans to repurchase shares worth between 60 million and 120 million RMB for employee stock ownership plans [15] - Pulite expects no large-scale orders for its LCP film products in the brain-computer interface sector in the short term [16] - Rijiu Optoelectronics plans to raise up to 800 million RMB through a private placement for a functional film project [17] Group 6 - Yingqu Technology forecasts a net profit increase of 114.69% to 162.4% in 2025, with expected revenue growth of 13% to 18% [19] - Shanda Electric has won a project from Southern Power Grid worth approximately 13.43 million RMB [20] - Changhong Technology's subsidiary has secured over half of a major semiconductor customer's procurement share, amounting to over 10 million RMB [21] Group 7 - Pairui Co. has signed a framework agreement for bulk procurement of IGBT chips, with projected orders totaling approximately 1.74 billion RMB [22] - Aimeike has received a drug registration certificate for its exclusive distribution of injectable botulinum toxin products in China [23] - Quanyin High-Tech's stock will resume trading after a takeover offer from Zhongzhong Group, which now holds 40.51% of the company [24] Group 8 - Hailiang Co. has decided to suspend its investment in Jinlong Group due to significant external changes [25] - Quanxin Co. plans to issue convertible bonds to raise up to 312 million RMB for aviation communication projects [26] - Kangtai Bio's clinical trial application for a combined vaccine has been accepted by the National Medical Products Administration [27] Group 9 - Huaxia Happiness expects to report a net loss for 2025, with losses projected to exceed the previous year's audited net assets [28] - Xianju Pharmaceutical has received a drug registration certificate for Betamethasone Sodium Phosphate Injection [29] - Huaxia Happiness's controlling shareholder is involved in arbitration with a claim amount of approximately 6.4 billion RMB [30] Group 10 - Shaoneng Co. has launched its smart control center project, with an investment of 8.7 million RMB [31] - Jiangshun Technology is planning to establish an investment fund with professional institutions, with details still under discussion [32] - Beifang Changlong intends to acquire 51% of Shunyi Technology, which may constitute a major asset restructuring [33] Group 11 - Guoji Heavy Industry's revenue from "controlled nuclear fusion" products is currently negligible [34] - Hongrun Construction's shareholder plans to reduce its stake by up to 0.12% [35] - Puni Testing expects a net loss of 200 to 250 million RMB for 2025, although this represents an improvement from the previous year's loss [36] Group 12 - Kede Education's controlling shareholder is planning a change in control through a share transfer agreement [38] - Zhongwei Company’s major shareholder plans to reduce its stake by up to 2% [39] - Tongcheng New Materials is planning to issue H-shares and apply for listing on the Hong Kong Stock Exchange [40] Group 13 - ST Jianyi's shareholder plans to reduce its stake by up to 1.23% [41]

Core Viewpoint - Minsheng Health (301507.SZ) plans to establish a partnership with Hangzhou Chaodao Equity Investment Fund Management Co., Ltd. and other limited partners to create the Hangzhou Nianfeng Yijian Equity Investment Partnership, focusing on investments in the health industry, particularly around the Minsheng health industry chain [1] Group 1 - The total fundraising scale for the partnership is set at 200 million yuan [1] - The company will contribute 98 million yuan as a limited partner, accounting for 49% of the total investment [1]

Core Viewpoint - Minsheng Health (301507.SZ) plans to establish a partnership with Hangzhou Chaodao Equity Investment Fund Management Co., Ltd. and other limited partners to create the Hangzhou Nianfeng Medical Health Equity Investment Partnership (Limited Partnership) [1] Group 1: Investment Details - The total fundraising scale for the partnership is set at 200 million yuan [1] - Minsheng Health will contribute 98 million yuan as a limited partner, accounting for 49% of the total investment [1] - The funds raised will primarily be used for equity investments in the health industry, focusing on the Minsheng health industry chain [1]

Core Viewpoint - The ownership of Southern Black Sesame has officially changed hands to Guangxi Travel Health Industry Group, with the actual controller now being the Guangxi State-owned Assets Supervision and Administration Commission, marking a significant shift in the company's future direction [1][2][3]. Group 1: Ownership Change - Southern Black Sesame's controlling shareholder has transitioned from Black Five Categories Group to Guangxi Travel Health, with the share transfer completed at a price of 6.25 yuan per share, totaling approximately 9.42 billion yuan [2][3]. - The transfer of shares was finalized on December 30, 2025, allowing Guangxi Travel Health to acquire about 20% of the company's shares, thus marking a strategic shift for the company [3][4]. Group 2: Financial Performance and Challenges - Southern Black Sesame has faced declining revenues for three consecutive years, with reported revenues of 30.16 billion yuan in 2022, 26.77 billion yuan in 2023, and 24.65 billion yuan in 2024, reflecting year-on-year declines of 25.07%, 11.25%, and 7.92% respectively [6][7]. - The company has signed a profit guarantee agreement requiring net profits to reach 1.15 billion yuan by 2028, with adjusted targets for 2026 and 2027 set at 0.95 billion yuan and 1.05 billion yuan respectively [5][6]. Group 3: Strategic Focus and Future Directions - The company aims to pivot towards a "big health" strategy, focusing on health food products and leveraging local resources to enhance brand competitiveness [9][12]. - Southern Black Sesame has established a diversified product matrix centered around black sesame paste, including health foods and beverages, and is working on product functionality and premiumization [9][12]. - The introduction of Guangxi State-owned assets is expected to provide financial support and enhance the company's operational capabilities, potentially revitalizing its brand and market position [4][10].

Core Viewpoint - The recent Central Economic Work Conference emphasized the importance of innovation-driven growth and green transformation, highlighting the need for companies to align with national strategies for sustainable development [1]. Group 1: Company Performance and Recognition - The company has been recognized as the global leader in the beauty and health instrument sector for two consecutive years (2023 and 2024) according to Euromonitor International, showcasing its strong market position [3]. - The company received multiple prestigious awards at the 2025 Global Makeup Awards, including silver for the best skincare product and bronze for the best moisturizing cream, reflecting its commitment to product excellence [3]. - The company has been awarded the title of "National Product and Service Quality Integrity Commitment Enterprise" by the China Quality Inspection Association, underscoring its dedication to quality management and consumer experience [5]. Group 2: Innovation and Product Development - The company integrates green principles into product innovation, focusing on sustainable raw material selection and eco-friendly packaging, which enhances consumer trust [5]. - The company has launched innovative products like the Prysm iO, which won the 2025 Blobee Business Awards for innovation, demonstrating its commitment to technological advancement [3]. Group 3: ESG Practices and Sustainability - The company has implemented comprehensive ESG practices, including carbon footprint management and green supply chain management, aligning with national goals for green transformation [9]. - The company has received multiple certifications for its sustainable practices, such as ISO 14064 for greenhouse gas management and recognition as a "Waste-Free Factory" [9]. - The company actively engages in social responsibility initiatives, receiving accolades for its charitable contributions and commitment to community welfare [11]. Group 4: Future Outlook - The company plans to continue responding to national economic strategies by focusing on technological innovation, green practices, and social responsibility, aiming to contribute to sustainable development and enhance consumer trust [13].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 告 全 部 或 任 何 部 份 內 容 而 產 生 或 因 倚 賴 該 等 內 容 而 引 致 之 任 何 損 失 承 擔 任 何 責 任。 Metaspacex Limited 中國數智科技集團有限公司 （於開曼群島註冊成立的有限公司） （股份代號︰1796） 自願性公告 戰略合作備忘錄 中 國 數 智 科 技 集 團 有 限 公 司（「本公司」，連 同 其 附 屬 公 司 統 稱「本集團」）謹 此 發 表 自 願 性 公 告，向 本 公 司 股 東 及 有 意 投 資 者 提 供 有 關 本 集 團 最 新 業 務 發 展 的 最 新 情 況。 訂立戰略合作備忘錄 本 公 司 董 事（「董 事」）會（「董事會」）謹 此 宣 佈，於 二 零 二 五 年 十 二 月 三 十 一 日，本 公 司 與 三 主 糧 集 團 股 份 公 司（「三主糧集團」）訂 立 了 一 項 戰 略 合 作 備 忘 錄（「戰 略 合作備忘錄」）。 ...

（来源：中国消费者报） 本报南宁讯（周艳英 记者顾艳伟）近日，记者从广西壮族自治区市场监管局获悉，今年以来，该局以 规范化、数字化、便利化为核心导向，创新构建"准入即监管、许可即服务"工作模式，通过完善许可规 范、建强专业队伍、优化审批服务、深化全链条监管等系列举措，全面优化食品生产准入管理流程，从 源头拧紧食品安全"总开关"，为广西食品产业高质量发展筑牢安全根基。 为破解食品生产许可管理中权限划分不清、地方特色食品审批难等痛点，广西出台了《食品生产许可管 理实施办法（试行）》（以下简称《办法》），构建标准统一、流程透明、监管闭环的许可管理制度体 系。《办法》明确自治区、市、县三级权责，推行一企一证、一证多址，支持全流程网办和跨层级联 办；实施风险分级治理，对高风险食品延续实行强制核查，建立信用约束机制，对不良企业"逢续必 查"；通过随机选派、异地交叉等核查机制确保审查公正，全方位实现许可服务提质增效。 专业化队伍是许可审查的核心支撑。广西以"资格考试+晋升考核+动态清理"三维机制优化核查人员库 管理，全年新晋核查组长48名、定向培养基层骨干166名、清理不合格人员67名、组建681人核心专业化 核查队伍。依 ...

Core Viewpoint - The company *ST Changyao is focusing on becoming a leading platform in the health industry, primarily engaged in the production and sales of traditional Chinese medicine, medicinal capsules, and the wholesale of pharmaceuticals, health products, and medical devices [1][10]. Group 1: Company Overview - *ST Changyao is classified under the pharmaceutical and biological sector, specifically in traditional Chinese medicine [2][10]. - The company aims to build an integrated pharmaceutical industry chain that includes the production of traditional Chinese medicine, hollow capsules, and a medical logistics network [1]. Group 2: Financial Misconduct - On November 7, 2025, the company received a notice from the China Securities Regulatory Commission regarding suspected false reporting of financial data [2][10]. - The company reported inflated revenues for 2021, 2022, and 2023, amounting to 215.32 million, 283.74 million, and 233.63 million yuan respectively, which represented 9.12%, 17.57%, and 19.51% of the disclosed revenues for those years [5][12]. - The inflated total profits for the same years were reported as 56.40 million, 63.38 million, and 43.71 million yuan, accounting for 35.62%, 88.23%, and 6.42% of the disclosed total profits [5][12]. Group 3: Investor Compensation - Investors who purchased shares between April 28, 2022, and November 7, 2025, and sold or continued to hold them after November 8, 2025, are eligible for compensation [5][12]. - Additionally, investors who bought shares between March 30, 2019, and April 29, 2024, and sold or continued to hold them after April 30, 2024, can also participate in the compensation [9][15]. Group 4: Financial Issues and Risks - As of April 30, 2024, the company disclosed significant financial issues, including a fund occupation amounting to 179.66 million yuan, which is 92.08% of the latest audited net assets [6][14]. - The company has acknowledged internal control deficiencies regarding non-operational fund occupation by its former general manager and related parties from 2019 to 2023 [7][14].

Core Insights - The company is experiencing a surge in demand for its flagship product, Jin Jiu, particularly among younger consumers, leading to supply shortages in some markets [2][3] - Jin Jiu is projected to grow by approximately 20% this year, while the overall company growth is expected to be around 10% [2] - The company has established a strong market position by focusing on health-oriented products and leveraging technological advancements in production [4][14] Group 1: Market Demand and Trends - There is a notable increase in Jin Jiu's popularity among young consumers, who are creatively mixing it with other beverages, thus enhancing its market presence [2][5] - The company has successfully attracted around 9 million new young users in the past two years, with approximately 4 million being female consumers [6] - The overall liquor industry is facing challenges, making Jin Jiu's growth particularly remarkable [3][10] Group 2: Product Development and Innovation - Jin Jiu has differentiated itself by combining traditional herbal ingredients with modern production techniques, establishing itself as a leader in the health liquor segment [4][18] - The company has invested over 3% of its annual revenue into research and development, leading to innovations in product quality and safety [14][15] - Jin Jiu's packaging and product offerings have been tailored to meet consumer demands for health and convenience, such as the introduction of smaller bottle sizes [11][26] Group 3: Corporate Philosophy and Sustainability - The company emphasizes a "four friendly" approach, focusing on user, customer, employee, and social friendliness to ensure sustainable growth [22][28] - It has implemented environmentally friendly practices, achieving 100% resource utilization of waste materials and being recognized as a national green factory [28][29] - The company has made significant contributions to social welfare, including investments in education and community water projects, totaling over 6 billion yuan [29][30]